基于生物电阻抗方法分析血液透析患者内脏脂肪面积与腹主动脉钙化的相关性研究

doi:10. 3969/ j. issn. 1006-7795. 2024. 01. 020

摘要/Abstract

摘要： 目的探讨维持性血液透析（maintenance hemodialysis，MHD）患者内脏脂肪面积（visceral fat area，VFA）与腹主动脉钙化的相关性。方法采用横断面调查法，选取2019年4月至2020年5月于首都医科大学附属北京潞河医院规律血液透析且保留完整数据的患者，进行人体成分分析，排除营养不良的患者，按照腹主动脉钙化评分(Abdominal Aortic Calcification Score，AACs)将患者按照钙化程度分成4组，比较临床特点及VFA水平；采用多因素Logistic 回归法分析患者腹主动脉钙化的影响因素，并通过受试者工作特征(receiver operating characteristic，ROC)曲线分析VFA水平对腹主动脉钙化的预测价值。结果本研究共纳入152例MHD患者，分为无钙化组（n=32）、轻度钙化组（n=45）、中度钙化组（n=54）以及重度钙化组（n=21）；4组患者的血磷、全段甲状旁腺素(intact parathyroid hormone，iPTH)、高密度脂蛋白胆固醇（high density lipoprotein-cholesterol，HDL-C）、VFA以及是否合并糖尿病指标比较，差异有统计学意义(P<0.05)。单因素相关分析显示非营养不良的MHD患者AACs评分与是否合并糖尿病、血磷、iPTH、VFA水平等均呈显著正相关（r=0.188、0.238、0.223、0.392，P<0.05），与HDL-C水平呈显著负相关(r=- 0.228,P<0.05)；多因素Logistic 回归分析显示，VFA以及血磷是MHD患者发生腹主动脉钙化的独立危险因素。ROC曲线显示，非营养不良的MHD患者体内VFA预测腹主动脉钙化的曲线下面积（area under the curve,AUC)为0.725（P<0.05），具有较高的预测价值。结论对于非营养不良的MHD 患者，VFA升高与腹主动脉钙化的严重程度相关，是腹主动脉钙化的独立危险因素，可能成为预测患者发生腹主动脉钙化的生物学指标。

关键词: 维持性血液透析, 人体成分分析, 内脏脂肪面积, 腹主动脉钙化

Abstract: Objective To investigate the correlation between visceral fat area (VFA) and abdominal aortic calcification in patients with maintenance hemodialysis (MHD). Methods Via cross-sectional survey,MHD patients in Beijing Luhe Hospital,Capital Medical University from April 2019 to May 2020 with complete data were selected and subjected to body composition analysis,excluding malnourished patients. The patients were divided into 4 groups according to the degree of calcium by Abdominal Aortic Calcification Score (AACs),and the clinical characteristics and VFA level were compared. Multivariate Logistic regression was used to analyze the risk factors of abdominal aortic calcification (AAC),and the predictive value of VFA level to abdominal aortic calcification was analyzed by receiver operating characteristic (ROC) curve. Results A total of 152 patients with MHD were included in this study and divided into non-AAC group (n=32),mild AAC group (n=45),moderate AAC group (n=54) and severe AAC group (n=21). There were statistically significant differences in serum phosphorus,intact parathyroid hormone (iPTH),high density lipoprotein-cholesterol (HDL-C),VFA and whether diabetes mellitus was combined among 4 groups (P < 0.05). Univariate correlation showed that AACs score of non-malnourished MHD patients was significantly positively correlated with diabetes,serum phosphorus,iPTH,and VFA level (r=0.188,0.238,0.223,0.392,P < 0.05),was negatively correlated with HDL-C level (r=-0.228,P < 0.05). Multivariate Logistic regression analysis showed that VFA and serum phosphorus were independent risk factors for AAC in MHD patients. ROC curve showed that the area under curve (AUC) of VFA in non-malnourished MHD patients for predicting AAC was 0.725 (P < 0.05),which had high predictive value. Conclusion For non-malnourished MHD patients,elevated VFA is associated with the severity of AAC and is an independent risk factor for AAC,which may be a biological indicator for predicting the occurrence of AAC.

Key words: maintenance hemodialysis, body composition analysis, visceral fat area, abdominal aortic calcification

中图分类号:

王小琪, 袁丹, 邵枫, 周晶晶, 杨帆, 李忠心. 基于生物电阻抗方法分析血液透析患者内脏脂肪面积与腹主动脉钙化的相关性研究[J]. 首都医科大学学报, 2024, 45(1): 127-132.

Wang Xiaoqi, Yuan Dan, Shao Feng, Zhou Jingjing, Yang Fan, Li Zhongxin. Correlation between visceral fat area and abdominal aortic calcification in hemodialysis patients based on bioelectrical impedance methods[J]. Journal of Capital Medical University, 2024, 45(1): 127-132.

0
/ / 推荐

导出引用管理器 EndNote|Reference Manager|ProCite|BibTeX|RefWorks

链接本文: https://journal03.magtech.org.cn/Jweb_sdykdxxb/CN/10. 3969/ j. issn. 1006-7795. 2024. 01. 020

https://journal03.magtech.org.cn/Jweb_sdykdxxb/CN/Y2024/V45/I1/127

参考文献

［1］Lee M J, Kim H K, Kim E H, et al. Association between muscle quality measured by abdominal computed tomography and subclinical coronary atherosclerosis［J］. Arterioscler Thromb Vasc Biol, 2021, 41(2): e128-e140.
［2］El Ati Z, Machfar H, Boussafa H, et al. Metabolic syndrome, malnutrition, and its associations with cardiovascular and all-cause mortality in hemodialysis patients: follow-up for three years［J］. Saudi J Kidney Dis Transpl, 2020, 31(1): 129-135.
［3］Nafakhi H, Al-Mosawi A, Elwali H, et al. Impact of body mass index on vascular calcification and pericardial fat volume among patients with suspected coronary artery disease［J］. Sultan Qaboos Univ Med J, 2016, 16(3): e310-e316.
［4］Xiong Y Q, Yu Y, Jiang H, et al. Visceral fat area is a better predictor than coronary artery calcification score for cardiovascular outcomes and All-cause death in patients on hemodialysis［J］. J Ren Nutr, 2021, 31(3): 306-312.
［5］Yang Y, Li L L, Zhang Y Y, et al. Association between coronary artery calcium score and bone mineral density in type 2 diabetes mellitus with different visceral fat area［J］. Diabetes Metab Syndr Obes, 2022, 15: 3949-3960.
［6］Cederholm T, Bosaeus I, Barazzoni R, et al. Diagnostic criteria for malnutrition—an ESPEN Consensus Statement［J］. Clin Nutr, 2015, 34(3): 335-340.
［7］Kauppila L I, Polak J F, Cupples L A, et al. New indices to classify location, severity and progression of calcific lesions in the abdominal aorta: a 25-year follow-up study［J］. Atherosclerosis, 1997, 132(2): 245-250.
［8］Xu C, Smith E R, Tiong M K, et al. Interventions to attenuate vascular calcification progression in chronic kidney disease: a systematic review of clinical trials［J］. J Am Soc Nephrol, 2022, 33(5): 1011-1032.
［9］Fujii H, Kono K, Watanabe K, et al. Evaluation of aortic calcification using a three-dimensional volume-rendering method in patients with end-stage kidney disease［J］. J Bone Miner Metab, 2021, 39(3): 439-445.
［10］Bellasi A, Di Lullo L, Russo D, et al. Predictive value of measures of vascular calcification burden and progression for risk of death in incident to dialysis patients［J］. J Clin Med, 2021, 10(3): 376.
［11］Chang M L, Yang Z, Yang S S. Roles of adipokines in digestive diseases: markers of inflammation, metabolic alteration and disease progression［J］. Int J Mol Sci, 2020, 21(21): 8308.
［12］Rosen E D, Spiegelman B M. What we talk about when we talk about fat［J］. Cell, 2014, 156(1/2): 20-44.
［13］Ouchi N, Parker J L, Lugus J J, et al. Adipokines in inflammation and metabolic disease［J］. Nat Rev Immunol, 2011, 11(2): 85-97.
［14］Xiao X, Liu Y Z, Cheng Z B, et al. Adipokines in vascular calcification［J］. Clin Chim Acta, 2021, 516: 15-26.
［15］Li Y L, Sun Z, Zhang L L, et al. Role of macrophages in the progression and regression of vascular calcification［J］. Front Pharmacol, 2020, 11: 661.
［16］Lee H L, Woo K M, Ryoo H M, et al.Tumor necrosis factor-alpha increases alkaline phosphatase expression in vascular smooth muscle cells via MSX2 induction［J］. Biochem Biophys Res Commun, 2010, 391(1): 1087-1092.
［17］Cheung A S, de Rooy C, Hoermann R, et al. Correlation of visceral adipose tissue measured by lunar prodigy dual X-ray absorptiometry with MRI and CT in older men［J］. Int J Obes (Lond), 2016,40(8):1325-1328.
［18］Berker D, Koparal S, I ik S, et al. Compatibility of different methods for the measurement of visceral fat in different body mass index strata［J］. Diagn Interv Radiol, 2010, 16(2): 99-105.
［19］Zhou C M, Peng H Y, Yuan J, et al. Visceral, general, abdominal adiposity and atherogenic index of plasma in relatively lean hemodialysis patients［J］. BMC Nephrol, 2018, 19(1): 206.
［20］Shang X W, Scott D, Hodge A, et al. Adiposity assessed by anthropometric measures has a similar or greater predictive ability than dual-energy X-ray absorptiometry measures for abdominal aortic calcification in community-dwelling older adults［J］. Int J Cardiovasc Imaging, 2016, 32(9): 1451-1460.
［21］Yurugi T, Morimoto S, Okamoto T, et al. Accumulation of visceral fat in maintenance hemodialysis patients［J］. Clin Exp Nephrol, 2012, 16(1): 156-163.
［22］Maruyama N, Higuchi T, Ono M, et al. Correlation between aortic calcification score and biochemical parameters in hemodialysis patients［J］. Contrib Nephrol, 2019, 198: 40-51.
［23］Biyik Z, Selcuk N Y, Tonbul H Z, et al. Assessment of abdominal aortic calcification at different stages of chronic kidney disease［J］. Int Urol Nephrol, 2016, 48(12): 2061-2068.

[1]	李玉佳, 官德秀, 郭姝, 郭景, 徐樨巍. 白细胞介素10受体A基因突变导致的极早发型炎症性肠病临床特点及基因分析[J]. 首都医科大学学报, 2024, 45(1): 140-148.
[2]	何振, 秦达, 李鹏, 朱圣韬, 冀明, 张澍田. 8字环辅助结直肠困难内镜下黏膜剥离术的临床效果评价[J]. 首都医科大学学报, 2023, 44(6): 973-977.
[3]	刘娟, 王文静, 赵桂平, 王拥军, 李鹏, 吴咏冬, 张澍田. 贲门失弛缓症经口内镜下肌切开术后复发危险因素分析[J]. 首都医科大学学报, 2023, 44(6): 978-981.
[4]	乔新伟, 邱煜婷, 李鹏, 吴静, 张澍田. 十二指肠乳头肿瘤患者的临床特征分析及其对肿瘤进展期的诊断价值[J]. 首都医科大学学报, 2023, 44(6): 990-998.
[5]	于明鑫, 杨爱明. 循环肿瘤DNA在消化系统肿瘤中的应用[J]. 首都医科大学学报, 2023, 44(6): 999-1005.
[6]	乔新伟, 邱煜婷, 李鹏, 吴静, 张澍田. 内镜下十二指肠乳头切除术后短期不良事件危险因素的初步探索[J]. 首都医科大学学报, 0, (): 982-989.
[7]	乔新伟, 邱煜婷, 李鹏, 吴静, 张澍田. 内镜下十二指肠乳头切除术后短期不良事件危险因素的初步探索[J]. 首都医科大学学报, 0, (): 982-989.
[8]	王亚丹, 王苗苗, 郭春梅, 台卫平, 刘红, 宿慧, 王沧海, 吴静. 急性胰腺炎严重程度早期预测模型的构建与验证[J]. 首都医科大学学报, 2023, 44(2): 302-310.
[9]	池添雨, 赵曲川. 胃黄色瘤合并肠上皮化生的临床分析[J]. 首都医科大学学报, 2023, 44(2): 322-327.
[10]	王芸, 李文坤, 苏珈仪, 王亚丹, 吴静. 系统免疫炎症指数在早期结直肠癌及癌前病变筛查中的应用价值[J]. 首都医科大学学报, 2022, 43(5): 760-766.
[11]	刘春涛, 苏珈仪, 旦增卓嘎, 伊比然恨, 卓玛, 张澍田. 西藏自治区藏族人群幽门螺杆菌毒力菌株分型与慢性胃炎及消化性溃疡的相关性研究[J]. 首都医科大学学报, 2022, 43(3): 463-468.
[12]	马鸣扬, 王洁玮, 李鹏. 细胞内镜评估结直肠病变的研究进展[J]. 首都医科大学学报, 2022, 43(2): 221-226.
[13]	苏珈仪, 刘春涛, 王铁山, 李文坤, 杨奕, 武珊珊, 李鹏, 吴静. 血清幽门螺杆菌抗体分型检测与胃黏膜病变的相关性[J]. 首都医科大学学报, 2022, 43(2): 216-220.
[14]	王荣欣, 王晶, 胡水清. 伴有食管外症状的反流性食管炎患者的危险因素分析[J]. 首都医科大学学报, 2022, 43(1): 132-137.
[15]	程芮, 朱思莹, 刘思茂, 周艳华, 宗晔, 李鹏, 张澍田. 内镜下治疗食管胃底静脉曲张伴发上消化道肿物的经验[J]. 首都医科大学学报, 2022, 43(1): 22-27.